skip to main content
Idioma:
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters
Busca Simples
Resultados 1 2 3 4 5 next page
Refinado por: Nome da Publicação: Annals of Oncology remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Clinical relevance of circulating tumor DNA using amplicon-based deep sequencing panel in colorectal cancer patients with liver metastasis
Clinical relevance of circulating tumor DNA using amplicon-based deep sequencing panel in colorectal cancer patients with liver metastasis
Material Type:
Artigo 		Adicionar ao Meu Espaço

Clinical relevance of circulating tumor DNA using amplicon-based deep sequencing panel in colorectal cancer patients with liver metastasis

Osumi, H ; Shinozaki, E ; Zembutsu, H ; Takeda, Y ; Wakatsuki, T ; Ichimura, T ; Ota, Y ; Nakayama, I ; Ogura, M ; Suenaga, M ; Takahari, D ; Chin, K ; Saiura, A ; Takahashi, S ; Noda, T ; Yamaguchi, K

Annals of oncology, 2018-10, Vol.29 Suppl 8, p.viii181 [Periódico revisado por pares]

England

Texto completo disponível

Citações Citado por
2
FDG-PET in T-cell and NK-cell neoplasms
FDG-PET in T-cell and NK-cell neoplasms
Material Type:
Artigo 		Adicionar ao Meu Espaço

FDG-PET in T-cell and NK-cell neoplasms

Kako, S. ; Izutsu, K. ; Ota, Y. ; Minatani, Y. ; Sugaya, M. ; Momose, T. ; Ohtomo, K. ; Kanda, Y. ; Chiba, S. ; Motokura, T. ; Kurokawa, M.

Annals of oncology, 2007-10, Vol.18 (10), p.1685-1690 [Periódico revisado por pares]

Oxford: Oxford University Press

Texto completo disponível

Citações Citado por
3
A high incidence of late-onset neutropenia following rituximab-containing chemotherapy as a primary treatment of CD20-positive B-cell lymphoma: a single-institution study
A high incidence of late-onset neutropenia following rituximab-containing chemotherapy as a primary treatment of CD20-positive B-cell lymphoma: a single-institution study
Material Type:
Artigo 		Adicionar ao Meu Espaço

A high incidence of late-onset neutropenia following rituximab-containing chemotherapy as a primary treatment of CD20-positive B-cell lymphoma: a single-institution study

Nitta, E. ; Izutsu, K. ; Sato, T. ; Ota, Y. ; Takeuchi, K. ; Kamijo, A. ; Takahashi, K. ; Oshima, K. ; Kanda, Y. ; Chiba, S. ; Motokura, T. ; Kurokawa, M.

Annals of oncology, 2007-02, Vol.18 (2), p.364-369 [Periódico revisado por pares]

Oxford: Elsevier Ltd

Texto completo disponível

Citações Citado por
4
A retrospective analysis of the association between perioperative carcinoembryonic antigen level and prognosis in stage III colorectal cancer
A retrospective analysis of the association between perioperative carcinoembryonic antigen level and prognosis in stage III colorectal cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

A retrospective analysis of the association between perioperative carcinoembryonic antigen level and prognosis in stage III colorectal cancer

Kozuki, R. ; Shinozaki, E. ; Osumi, H. ; Wakatsuki, T. ; Suenaga, M. ; Ichimura, T. ; Ogura, M. ; Suzuki, T. ; Ota, Y. ; Nakayama, I. ; Takahari, D. ; Chin, K. ; Nagasaki, T. ; Akiyoshi, T. ; Konishi, T. ; Fujimoto, Y. ; Nagayama, S. ; Fukunaga, Y. ; Ueno, M. ; Yamaguchi, K.

Annals of oncology, 2018-11, Vol.29, p.ix42-ix42 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
5
A phase I study to determine the maximum tolerated dose of trifluridine/tipiracil and oxaliplatin in patients with refractory metastatic colorectal cancer: LUPIN study
A phase I study to determine the maximum tolerated dose of trifluridine/tipiracil and oxaliplatin in patients with refractory metastatic colorectal cancer: LUPIN study
Material Type:
Artigo 		Adicionar ao Meu Espaço

A phase I study to determine the maximum tolerated dose of trifluridine/tipiracil and oxaliplatin in patients with refractory metastatic colorectal cancer: LUPIN study

Suenaga, M ; Wakatsuki, T ; Ogura, M ; Ichimura, T ; Shinozaki, E ; Nakayama, I ; Osumi, H ; Ota, Y ; Chin, K ; Mashima, T ; Seimiya, H ; Takahari, D ; Yamaguchi, K

Annals of oncology, 2018-10, Vol.29 Suppl 8, p.viii158 [Periódico revisado por pares]

England

Texto completo disponível

Citações Citado por
6
Early outcomes of a pilot study of neoadjuvant chemotherapy with S-1 plus oxaliplatin at dose of 130mg/m2 (nacG-SOX130) in stage III gastric cancer
Early outcomes of a pilot study of neoadjuvant chemotherapy with S-1 plus oxaliplatin at dose of 130mg/m2 (nacG-SOX130) in stage III gastric cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Early outcomes of a pilot study of neoadjuvant chemotherapy with S-1 plus oxaliplatin at dose of 130mg/m2 (nacG-SOX130) in stage III gastric cancer

Konishi, S. ; Manaka, D. ; An, H. ; Nishikawa, Y. ; Ota, T. ; Kudo, R. ; Kawaguchi, K. ; Hamasu, S. ; Nishitai, R.

Annals of oncology, 2018-06, Vol.29, p.v18-v18 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
7
A phase II study of dose-escalation of regorafenib for patients with previously treated metastatic colorectal cancer – DEREGULATE study - Trial in progress
A phase II study of dose-escalation of regorafenib for patients with previously treated metastatic colorectal cancer – DEREGULATE study - Trial in progress
Material Type:
Artigo 		Adicionar ao Meu Espaço

A phase II study of dose-escalation of regorafenib for patients with previously treated metastatic colorectal cancer – DEREGULATE study - Trial in progress

Kawaguchi, K. ; Nishitai, R. ; Manaka, D. ; Ota, T. ; Nishikawa, Y. ; Kudo, R. ; An, H. ; Hamasu, S. ; Konishi, S.

Annals of oncology, 2018-06, Vol.29, p.v82-v82 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
8
Analysis of clinical outcomes of two antiEGFR antibodies, cetuximab and panitumumab, in the 1st line chemotherapy of RAS wild metastatic colorectal cancer, by neutrophil-to-lymphocyte ratio (NLR) kinetics
Analysis of clinical outcomes of two antiEGFR antibodies, cetuximab and panitumumab, in the 1st line chemotherapy of RAS wild metastatic colorectal cancer, by neutrophil-to-lymphocyte ratio (NLR) kinetics
Material Type:
Artigo 		Adicionar ao Meu Espaço

Analysis of clinical outcomes of two antiEGFR antibodies, cetuximab and panitumumab, in the 1st line chemotherapy of RAS wild metastatic colorectal cancer, by neutrophil-to-lymphocyte ratio (NLR) kinetics

Manaka, D. ; Nishitai, R. ; Konishi, S. ; Ota, T. ; Nishikawa, Y. ; Kudo, R. ; Kawaguchi, K. ; An, H. ; Hamasu, S.

Annals of oncology, 2018-06, Vol.29, p.v63-v63 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
9
Amrubicin in patients with platinum-refractory metastatic neuroendocrine carcinoma of the gastrointestinal tract
Amrubicin in patients with platinum-refractory metastatic neuroendocrine carcinoma of the gastrointestinal tract
Material Type:
Artigo 		Adicionar ao Meu Espaço

Amrubicin in patients with platinum-refractory metastatic neuroendocrine carcinoma of the gastrointestinal tract

Osumi, H. ; Shinozaki, E. ; Chin, K. ; Takahari, D. ; Ogura, M. ; Ichimura, T. ; Wakatsuki, T. ; Ota, Y. ; Nakayama, I. ; Suenaga, M. ; Yamaguchi, K.

Annals of oncology, 2018-06, Vol.29, p.v29-v29 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
10
Is the PEG-G-CSF useful as the prevention for the severe neutropenia in metastatic colorectal cancer patients treated with FOLFOXIRI plus bevacizumab?
Is the PEG-G-CSF useful as the prevention for the severe neutropenia in metastatic colorectal cancer patients treated with FOLFOXIRI plus bevacizumab?
Material Type:
Artigo 		Adicionar ao Meu Espaço

Is the PEG-G-CSF useful as the prevention for the severe neutropenia in metastatic colorectal cancer patients treated with FOLFOXIRI plus bevacizumab?

Osumi, H. ; Shinozaki, E. ; Wakatsuki, T. ; Suenaga, M. ; Ichimura, T. ; Ogura, M. ; Ota, Y. ; Nakayama, I. ; Takahari, D. ; Chin, K. ; Yamaguchi, K.

Annals of oncology, 2018-06, Vol.29, p.v62-v62 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.